2016 American Transplant Congress

Tuesday, June 14, 2016

4:42pm-4:54pm

Induction Therapy with Depleting Antibodies in Low Immunological Risk Renal Transplant Patients Treated with a Steroid Free Regimen – Comparison of Alemtuzumab vs. Antithymocyte Globulin.

N. Bossini,¹ S. Sandrini,¹ R. Tardanico,² F. Valerio,¹ G. Setti,¹ C. Salviani,¹ S. Possenti,¹ P. Foini,¹ E. Marta,¹ G. Cancarini.¹

Concurrent Session: Kidney: Induction Therapy 2  •  Room 312

4:42pm-4:54pm

Mechanistic Insights into How Targeting of HDAC10 Promotes Foxp3+ Treg Cell Suppressive Activity, Gene Expression and Metabolism, and Enhances Allograft Survival.

S. Dahiya,¹ L. Wang,¹ U. Beier,^1,2 A. Angelin,¹ R. Han,¹ D. Wallace,^1,2 W. Hancock.^1,2

Concurrent Session: Novel Approaches and Potential Targets for Promoting Tolerance: Animal Models  •  Room 310

4:42pm-4:54pm

Non-Invasive – Minimalistic Approach Using Cell-Free MicroRNAs in Paired Plasma and Urine Samples for Early Diagnosis of Chronic Renal Allograft Dysfunction.

S. Bontha,¹ R. Gehrau,¹ E. Rhone,¹ A. King,² L. Gallon,³ K. Brayman,¹ D. Maluf,¹ V. Mas.¹

Concurrent Session: Kidney Transplant Recipient: Long Term Outcomes Session 2  •  Ballroom A

4:42pm-4:54pm

Normothermic Ex-Vivo Perfusion of the Intestine: The Introduction of an Innovative Physiologic Model with Novel Biomarkers.

B. Soliman, T. Okamoto, C. Quintini, Q. Liu, M. Fujiki, A. Khanna, K. Hashimoto, J. Fung, K. Abu-Elmagd.

Concurrent Session: Small Bowel Transplantation  •  Room 102

4:42pm-4:54pm

Post Transplantation High-Dose Cyclophosphamide Treatment Promotes Immune Tolerance After Skin, Solid Organ, and Vascularized Composite Allotransplantation.

G. Furtmüller,¹ B. Oh,¹ M. Fryer,^1,4 P. Akre,¹ S. Ganguly,² J. Dodd-o,³ D. Cooney,¹ G. Raimondi,¹ W. Lee,¹ L. Luznik,² G. Brandacher.¹

Concurrent Session: Bone Marrow Transplantation and Chimerism: Animal Models  •  Room 313

4:42pm-4:54pm

Pre-Donation Weight Loss Postpones Living Kidney Donation without Attaining the Desired Weight Maintenance in the Midterm.

P. Ventura-Aguiar, E. De Sousa-Amorim, J. Campistol, F. Diekmann, F. Oppenheimer, I. Revuelta.

Concurrent Session: Living Kidney Donor Evaluation  •  Ballroom B

4:42pm-4:54pm

Significant Increase in Wait List Removals for Candidates Considered Too Sick from the US Kidney Transplant Waiting List.

E. Poggio, L. Buccini, S. Flechner, D. Goldfarb, J. Schold.

Concurrent Session: Kidney Waitlist Management and KAS Initial Results  •  Veterans Auditorium

4:42pm-4:54pm

The Impact of One Year Individual or Dual Organ Rejection in Simultaneous Pancreas-Kidney Transplant on Kidney Graft Survival – A UNOS Registry Analysis 2000-2013.

I. Moinuddin,¹ T. Taber,¹ M. Yaqub,¹ O. Adebiyi,¹ M. Mujtaba,¹ J. Chen,² M. Goble,² D. Mishler,¹ J. Fridell,² A. Sharfuddin.¹

Concurrent Session: Clinical Pancreas Transplantation 2  •  Room 210

4:42pm-4:54pm

The Relationship Between Kidney Donor Profile Index and Six Month eGFR in Deceased Donor Recipients.

D. Keith, A. Nishio Lucar, G. Vranic.

Concurrent Session: The High KDPI Kidney: Outcomes and Optimal Utilization  •  Ballroom C

4:54pm-5:06pm

Analysis of Local versus Imported Expanded Criteria Donor (ECD) Kidneys: A Single Center Experience with 497 ECD Kidney Transplants.

M. Khan,¹ H. El-Hennawy,¹ A. Farney,¹ J. Rogers,¹ G. Orlando,¹ A. Reeves-Daniel,² A. Palanisamy,² M. Gautreaux,³ S. Iskandar,³ W. Doares,⁴ S. Kaczmorski,⁴ R. Stratta.¹

Concurrent Session: The High KDPI Kidney: Outcomes and Optimal Utilization  •  Ballroom C